Equity Overview
Price & Market Data
Price: $0.08
Daily Change: -$0.025 / 31.23%
Range: $0.0751 - $0.105
Market Cap: $7,099,961
Volume: 65,400
Performance Metrics
1 Week: 25.00%
1 Month: -4.85%
3 Months: 4.17%
6 Months: 42.86%
1 Year: -44.44%
YTD: -29.13%
Details
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert for determining smoking status; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas.